SCK CEN And TerThera Collaborate To Secure Terbium-161 Supply
SCK CEN And TerThera Collaborate To Secure Terbium-161 Supply SCK CEN (ENS Corporate Member) and TerThera signed an agreement to handle together the production process of Terbium-161, a promising novel radionuclide for cancer treatment. Terbium-161 can meet the growing demand in cancer healthcare, exhibiting comparable (radio)chemical characteristics to known radiolanthanides. Targeted cancer therapies with Terbium-161 are expected…